Email RIS file
Bookmark
Report an Issue

New Anti-cancer Drug Development and Evaluation [electronic resource] / edited by Yongchang Zhang, Nong Yang

Published
Singapore : Springer Nature Singapore : Imprint: Springer, 2024.
Edition
1st ed. 2024.
Physical Description
XXVII, 232 p. 200 illus. online resource
Additional Creators
Zhang, Yongchang, Yang, Nong, and SpringerLink (Online service)
Access Online

Availability

I Want It
I Want It

Finding items...

Contents
Chapter 1. Transformations and Challenges in Cancer Treatment -- Chapter 2. Drug(gable) Targets Discovery -- Chapter 3. Preclinical and Translational Study Design -- Chapter 4. Clinical Trials -- Chapter 5. Small Molecule Compounds -- Chapter 6. Antibodies -- Chapter 7. Cell Guided Drugs -- Chapter 8. Gene Guided Drugs -- Chapter 9. Biosimilar -- Chapter 10. New Insights on Success and Failed Drugs -- Chapter 11. The Road from Laboratory to Patient.
Summary
This book aims to help researchers to understand the current status of new drug development in China and major events experienced in the development of new drugs. It also helps clinicians and basic research scientists to grasp the types, indications, and adverse reactions of common new drugs; clarifies key events experienced during the launch of new drugs; and discusses future perspectives of clinical medicine development. This book is also beneficial to clinicians by helping them to better become physician scientists.
Subject(s)
ISBN
9789819772742
Digital File Characteristics
text file PDF
Part Of
Springer Nature eBook
View MARC record | catkey: 46162791